High-frequency oscillatory ventilation (HFOV)
HFOV · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Extreme lung-protective concept: sub-deadspace tidal volumes (1–3 mL/kg) at 3–6 Hz oscillating around a high continuous distending pressure — effectively CPAP with superimposed oscillations clearing CO₂ by enhanced diffusion/mixing.
Red flags
- 2020s update: routine adult HFOV showed NO benefit (OSCAR) and HARM (OSCILLATE) — abandoned as standard adult ARDS therapy; consider only exceptional rescue in experienced centres
- Loss of spontaneous breathing and heavy sedation are real costs
Management
- Historically rescue for refractory ARDS hypoxaemia; requires deep sedation ± paralysis
- Set continuous distending pressure stepwise to an oxygenation/CXR target; frequency 3–6 Hz for CO₂
- Volume-load before starting — haemodynamic compromise is common
- Pneumothorax risk similar to conventional ventilation but harder to detect — scan/X-ray on deterioration
Of historical/rescue interest in adults — prone positioning and ECMO have superseded it.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.